CD44 and pancreatic neoplasm: Silibinin, a flavonolignan composed of two diastereomers (silibinin A and B), strongly inhibited the activity of the CD44 promoter in the prostate (PC-3M) and pancreatic cancer cell lines (BxPC-3 and PANC-1) (190, 191).